Stability Indicating Analytical Method Development and Validation for the Estimation of Rimegepant in Bulk and Its Tablets Using Rp-HPLC
H. M. Sudheer Kumar & Kothapalli Bannoth Chandrasekhar · Journal of Pharmaceutical Research International · 2021
Aim: Ramegepant is a novel molecule belongs to the class of calcitonin gene – related peptide (CGRP) receptor antagonist, which was developed for the prevention and treatment of migraine. Ramegepant was reported to act at the CGRP receptor with good oral bioavailability. The obje...
Open access
Research Article
10.9734/jpri/2021/v33i431170